GVALX
Price
$13.74
Change
-$1.84 (-11.81%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

GVALX vs RMFCX

Header iconGVALX vs RMFCX Comparison
Open Charts GVALX vs RMFCXBanner chart's image
Gotham Large Value Institutional
Price$13.74
Change-$1.84 (-11.81%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
GVALX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVALX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVALX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. GVALX (33.4M). RMFCX pays higher dividends than GVALX: RMFCX (1.69) vs GVALX (1.40). GVALX was incepted earlier than RMFCX: GVALX (9 years) vs RMFCX (23 years). GVALX is a more actively managed with annual turnover of: 191.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than GVALX: RMFCX (250) vs GVALX (100000). GVALX annual gain was more profitable for investors over the last year : 15.24 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. GVALX (17.70).
GVALXRMFCXGVALX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD14.22311.423125%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets33.4M98.7B0%
Annual Yield % from dividends1.401.6982%
Returns for 1 year15.2412.63121%
Returns for 3 years6.6114.1647%
Returns for 5 years17.7040.3944%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc